Thanks NYC I appreciate your confidence. I expect

New Post Public Reply Private Reply Replies (4) Message Board
otctrader NYCFITX #33266
Thanks NYC

I appreciate your confidence.

I expect there are shareholders that will wear down and start selling off shares as time goes by. Judging from what I read and see happening in this sector it is apparant that some shareholders do not have confidence that license will be granted and PPS will continue dropping with no recovery in sight. IMO, one day the shareholders that just can't stay the course will one day be saying....if only I had kept the shares I once owned.

There will be winners and losers in this sector.
There will be many twists and turns yet to come and at times the entire sector will look very unappealing for shareholders.
This should be expected. It's a new market segment which will struggle through negative perceptions, unscrupulous business practices, market maker manipulations, PR pumping and dumping, bashers, government timetables, legal setbacks and the list goes on. This is inevitable.

This market is here to stay
and will prosper despite the many negative influences.

Why?
1.MARKET DEMAND
2.TAX REVENUES

It's really just that simple.

There are several companies in this sector to keep an eye on for the serious investor and FITX stands to lose shareholder support as competitors come online. Its' up to the CEO and BOD to determine the best manner to instill shareholder confidence and loyalty.

For any company, due diligence should include:
Corporate and Share structure, Corporate Filings,
BOD (ability to enter larger capital markets)
Initial and ongoing Capitalization (Debt/Equity and structuring)
JV Partners (areas of expertise and impact on shareholders)
M&A (Short and long term objectives)
Any other agreements affecting shareholders
Disclosure (this is a big one IMO because it's your shareholder money that is at risk)
Ability of Vertical Entry into larger markets
Legal aspects pertaining to the market
Political influences pertaining to the market.

I am long in FITX. IMO FITX share structure, previous PHOT JV, failure to perform on GNC are all "Red Flag" issues. Despite this I do believe the license will be issued and the value of that license (once issued) will initially be significant to PPS. The performance then will become an issue although I expect the FITX CEO will quickly want to move into an up listing based on early momentum. After that occurs, shareholders will want to carefully watch this and competitive companies over the next several years as the market continues emerging.

As I have said, I am long FITX. I don't always agree with what I see taking place (share structure, PHOT JV, GNC,etc) I believe that these were decisions made early on that were really designed more towards boosting PPS while creating an early exit plan for insiders or alternately, a plan designed to capitalize future expansion with insiders then in effect utilizing a revenue sharing scheme to pull profits off the top after the company became licensed.

I do feel the BOD collectively understands the distinction between real growth potential and short term profit taking and are working to orient the company for sustained growth.

IMO, the company, despite its early start, will one day be the giant of the industry. Clearly, it has the potential. That is why I am long FITX



Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Home Repair Shock: 85% Hit by Unplanned Costs in 2025

Updated Category News Views 142

New findings hit the floor: a staggering 85% of American homeowners coughed up cash for unplanned repairs in 2025. That’s not just pocket change; over one-third, about 38%, forked out at least $5,000 on home renovation projects. And if you're thinking that's a fluke, wait until you hear that nearly a quarter of folks (23%) dug even deeper, spending upwards of $10,000....

Continue Reading
Genialis and Debiopharm Expand Collaboration for Cancer Drug Innovation

Updated Category News Views 150

Genialis and Debiopharm's Strategic Collaboration Genialis, a pioneering RNA biomarker company, has recently announced an exciting extension of its collaboration with Debiopharm, a global biopharmaceutical leader. This partnership aims to develop predictive biomarkers specifically for therapies targeting the WEE1 protein, which is crucial in the treatment landscape of...

Continue Reading
Telecom Providers Fight Robocalls with Enhanced Solutions

Updated Category News Views 411

Progress in Robocall Mitigation by Major Telecom Providers In recent developments, top US telecom providers such as Verizon, UScellular, T-Mobile, Lumen, Comcast, Charter, and AT&T have made significant strides in maximizing their efforts against robocalls. This progress is largely attributed to the successful implementation of the STIR/SHAKEN framework, which aids in...

Continue Reading
OpenSea Unveils OS2: A Major Step Forward with $SEA Token

Updated Category News Views 238

OpenSea Launches OS2 Platform with Enhanced Trading Features The innovative marketplace, OpenSea, has rolled out its new platform known as OS2, which represents a significant transformation from its original NFT-centric model into a comprehensive trading space. This upgrade broadens its scope, allowing not just the buying and selling of NFTs but also the trading of...

Continue Reading
Experience the Future of Communications at Telecoms World Asia

Updated Category News Views 44

Join DIDWW at Telecommunications World Asia DIDWW, a renowned global provider of premium VoIP communications, is set to showcase its innovative voice and SMS solutions at the upcoming Telecoms World Asia event. This exhibition represents an incredible opportunity for telecommunications experts and businesses looking to enhance their communication strategies. What to...

Continue Reading